Using metabolomics and artificial intelligence to explore the universe of the dark metabolome

Using metabolomics and artificial intelligence to explore the universe of the dark metabolome

Professor David Wishart, University of Alberta, is a member of Canada’s national metabolomics laboratory and leads the Human Metabolome Project. His work aims to identify and catalogue metabolites in human tissues, biofluids and the surrounding environment. He has developed a software package called BioTransformer, which is a chemical prediction tool to explore the mysterious dark metabolome. The program combines artificial […]

Read More…

Preventing and treating complications of heart failure and Fabry disease

Dr Gavin Y Oudit, a distinguished cardiologist from the University of Alberta, focuses his research on developing ground-breaking therapies to treat both genetic and non-genetic cardiovascular disorders, and to prevent heart failure. His exciting work into the role of ACE2 has provided a fundamental scientific understanding used in the development of therapeutic options for cardiovascular, renal and lung diseases. He […]

Read More…